Pharmafile Logo

Glaucoma in perspective

- PMLiVE

FDA green light for Pfizer’s eczema drug

Blockbuster-hopeful Eucrisa expected to launch early next year at $580 per 60mg tube

- PMLiVE

Intercept gets EU nod for rare liver disease therapy

Ocaliva approved as a combination treatment for primary biliary cholangitis

Lucid logo

Medical communications that improve outcomes and value to patients

In 2017, Lucid aims to advance its approach to measuring the impact of its behaviour-change programmes, building on the existing evidence-base to develop new approaches to capturing metrics on value...

- PMLiVE

PC: Patient-centricity or merely politically correct?

It is time that pharma started prioritising patient-centricity activities, so that the concept becomes something that patients notice and benefit from, rather than just a mantra

- PMLiVE

Arquer Diagnostics appoints CEO

Nadia Whittley takes up the lead role at the oncology diagnostics firm

IFPMA elects Pfizer’s Ian Read as president

Read succeeds Merck KGaA’s Dr Stefan Oschmann for a two-year term

A Bitter Pill?

The ideal route of admin isn’t clear cut in the global marketplace

Inizio

- PMLiVE

Digital home care platform launched in the UK

The Vida service matches carers with clients to bridge home care gaps

Actelion HQ Switzerland

J&J abandons talks with Actelion as another suitor circles

Biotech said to be holding out for a higher offer as speculation of Sanofi interest builds

- PMLiVE

AZ’s Lisa Anson elected president of ABPI

She takes up the lead role from April 2017

Bristol-Myers Squibb (BMS) building

BMS restructures US R&D operations

Unveils site closures and build plans as firm focuses pipeline around three US hubs

- PMLiVE

QuintilesIMS launches European oncology data-gathering initiative

Will collaborate with Bristol-Myers Squibb, Lilly, Merck KGaA and Pfizer

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links